Evaluation of prophylactic effect of Livergol (Silymarin) on liver function tests in patients with outpatient cancer undergoing chemotherapy
Phase 3
Recruiting
- Conditions
- Chemotherapy induced liver injury.Injury of liverS36.11
- Registration Number
- IRCT20201123049474N2
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
Patients aged 30 to 60 years
Ability to take the drug orally
Definitive diagnosis of breast cancer that has chemotherapy indications and has not yet received its chemotherapy drug
Liver tests are normal before the intervention
Indication of treatment with chemotherapy regimen
Exclusion Criteria
pregnant and breastfeeding
liver metastasis and liver disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver function test. Timepoint: Measurement of liver enzymes at the beginning of the study (before the intervention) and 3 and 6 weeks after the start of silymarin. Method of measurement: Lab data.
- Secondary Outcome Measures
Name Time Method